Eli Lilly and Co. has received the Federal Drug Administration’s breakthrough therapy designation for a drug in development ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA damage response. 3,4 Upon PARG inhibition, the agent is intended to ...

More than two-thirds of deaths from ovarian cancer are attributable to high-grade serous carcinoma. In one particularly ...

Sofetabart mipitecan is an antibody-drug conjugate consisting of an Fc-silent, folate receptor alpha specific monoclonal antibody attached to an exatecan payload.

After Corcept Therapeutics setback with relacorilant in Cushing syndrome last month, the company has bounced back with strong data in ovarian cancer, firming its share price. Corcept's stock fell ...

BioVaxys Technology Corp. (CSE:BIOV) (USOTC:BVAXF) said it has reported positive early results from its Phase 1B/2 PESCO ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for providing insights into molecular changes linked to early ovarian cancer ...

ARTISTRY-7 trial showed no significant survival benefit for nemvaleukin and Keytruda over chemotherapy in platinum-resistant ovarian cancer. Mural Oncology will cease nemvaleukin development for this ...

Scientists from University of California, Los Angeles, Harvard University, and elsewhere have developed what they claim is the first comprehensive road map of how the ovarian reserve forms in primates ...

A microscopy image of the outer region of the rhesus macaque ovary. The developing egg cells are marked by VASA protein (green) and surrounded by supporting granulosa cells marked by FOXL2 (magenta) ...